A one-stone–three-birds strategy for disc degeneration: Constructing an injectable bioactive matrix hydrogel with anti-angiogenic and anti-neurogenic microenvironments
Source abstract
Abstract
The therapy for intervertebral disc degeneration (IDD) presents a significant challenge globally. In this study, an innovative "one-stone–three-birds" strategy that can inhibit the generation of blood vessels and nerves while reconstructing the intervertebral disc matrix structure was developed by incorporating concentrated growth factors (CGF), bevacizumab, and methacrylated chondroitin sulfate (CSMA) to prepare cbCSMA. Results revealed that 5% CSMA, 10 μg/mL bevacizumab, and 10 mg/mL CGF were the optimal concentrations. Subsequently, cbCSMA exhibited good biocompatibility, biological functions, and no organ toxicity. Further in vivo repair results indicated that cbCSMA could significantly inhibit angiogenesis and neurogenesis, thereby regulating local immune-inflammatory responses. Ultimately, cbCSMA can significantly enhance the secretion of cartilage-specific proteins and polysaccharides, thereby achieving effective IDD repair and cartilage regeneration. Finally, mechanistic analysis revealed that cbCSMA can activate cartilage regeneration–related signaling pathways, such as cartilage development, TGF-beta signaling pathway, and MAPK signaling pathway, thereby confirming that cbCSMA can regulate cartilage regeneration from multiple aspects, leading to effective IDD repair.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Spine and Intervertebral Disc Pathology · Wound Healing and Treatments · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. What a pain in the back: etiology, diagnosis and future treatment directions for discogenic low back pain10.1038/s41413-025-00472-7 ↗
2. Low back pain10.1016/S0140-6736(21)00733-9 ↗
3. Incidence, prevalence and risk factors for low back pain in adolescent athletes: a systematic review and meta-analysis10.1136/bjsports-2021-104749 ↗
4. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis10.1136/bmj.n1446 ↗
5. A One‐Stone‐Two–Birds strategy for intervertebral disc repair: constructing a reductive chelation hydrogel to mitigate oxidative stress and promote disc matrix reconstruction10.1002/adma.202411290 ↗
6. Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions10.1038/s41413-020-00125-x ↗
7. The Nrf2 antioxidant defense system in intervertebral disc degeneration: molecular insights10.1038/s12276-022-00829-6 ↗
8. Modulating macrophage–nucleus pulposus cell crosstalk via sequential drug delivery attenuates disc degeneration10.1002/advs.202507178 ↗
9. Cellular and molecular mechanisms underlying obesity in degenerative spine and joint diseases10.1038/s41413-024-00388-8 ↗
10. Mitochondrial quality control in intervertebral disc degeneration10.1038/s12276-021-00650-7 ↗
11. Epigenetic modifications of inflammation in intervertebral disc degeneration10.1016/j.arr.2023.101902 ↗
12. Emerging role and therapeutic implication of mTOR signalling in intervertebral disc degeneration10.1111/cpr.13338 ↗
13. The role of structure and function changes of sensory nervous system in intervertebral disc-related low back pain10.1016/j.joca.2020.09.002 ↗
14. NanoCRISPR-assisted biomimetic tissue-equivalent patch regenerates the intervertebral disc by inhibiting endothelial-to-mesenchymal transition10.1016/j.biomaterials.2025.123404 ↗
15. Synergistic reversal of inflammation-mediated degeneration in intervertebral discs: phenylboric acid-grafted hyaluronic acid hydrogel as an anti-oxidative vehicle for Timp-3 delivery and promotion of extracellular matrix synthesis10.1016/j.actbio.2025.06.011 ↗
16. AF cell derived exosomes regulate endothelial cell migration and inflammation: implications for vascularization in intervertebral disc degeneration10.1016/j.lfs.2020.118778 ↗
17. Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis10.1038/s41467-025-56727-8 ↗
18. Injectable pathological microenvironment-responsive anti-inflammatory hydrogels for ameliorating intervertebral disc degeneration10.1016/j.biomaterials.2024.122509 ↗
19. Decellularized Disc Hydrogels for hBMSCs tissue-specific differentiation and tissue regeneration
20. Injectable hydrogel microspheres promoting inflammation modulation and nucleus pulposus-like differentiation for intervertebral disc regeneration10.1016/j.jconrel.2025.02.016 ↗
21. Self-healing hydrogels loaded with Spatholobi Caulis alleviate disc degeneration by promoting autophagy in nucelus pulposus
22. Multifunctional annulus fibrosus matrix prevents disc-related pain via inhibiting neuroinflammation and sensitization10.1016/j.actbio.2023.08.028 ↗
23. Harnessing Thrombospondin‐1‐Enabled decellularized nucleus pulposus matrices and elastin‐like recombinamers to rebuild an avascular analogue of the intervertebral disc10.1002/jbm.a.37911 ↗
24. Hydrogel delivery systems in intervertebral disc degeneration: current status and future perspectives10.1016/j.jconrel.2025.114066 ↗
25. In vivo stable allogenic cartilage regeneration in a goat model based on immunoisolation strategy using electrospun semipermeable membranes
26. Dominant role of in situ native cartilage niche for determining the cartilage type regenerated by BMSCs
27. Living and injectable porous hydrogel microspheres promoting inflammation modulation and extracellular matrix remodeling for intervertebral disc regeneration
28. Bio-engineered thermo-sensitive alginate/PNIA-g-CS co-polymeric injectable hydrogel laden with GDF-5 to stimulate nucleus pulposus for IVD regeneration10.1186/s13036-025-00520-0 ↗
29. IL-1ra loaded chondroitin sulfate-functionalized microspheres for minimally invasive treatment of intervertebral disc degeneration10.1016/j.actbio.2024.06.048 ↗
30. Creating a functional biomimetic cartilage implant using hydrogels based on methacrylated chondroitin sulfate and hyaluronic acid10.3390/gels8070457 ↗
31. Marine gelatin-methacryloyl-based hydrogels as cell templates for cartilage tissue engineering10.3390/polym15071674 ↗
32. Fabrication of 3D-Printed interpenetrating hydrogel scaffolds for promoting chondrogenic differentiation10.3390/polym13132146 ↗
33. CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway10.1186/s13287-024-03959-y ↗
34. Use of PRP, PRF and CGF in periodontal regeneration and facial rejuvenation—A narrative review10.3390/biology10040317 ↗
35. Instructions for the use of L‐PRF in different clinical indications10.1111/prd.12564 ↗
36. Matrix stiffness triggers lipid metabolic cross-talk between tumor and stromal cells to mediate bevacizumab resistance in colorectal cancer liver metastases10.1158/0008-5472.CAN-23-0025 ↗
37. Optimal bevacizumab treatment strategy in advanced ovarian cancer: a review10.1016/j.ctrv.2025.102945 ↗
38. A mussel-inspired, antibacterial, antioxidant, injectable composite hydrogel for the sustain delivery of salvianolic acid B for the treatment of frozen shoulder
39. Repair of large-scale rib defects based on steel-reinforced concrete-designed biomimetic 3D-Printed scaffolds with bone-mineralized microenvironments10.1021/acsami.2c08422 ↗
40. Tolerant and rapid endochondral bone regeneration using framework‐enhanced 3D biomineralized matrix hydrogels10.1002/advs.202305580 ↗
41. Spinal cord‐like scaffold with rapid tissue integration enhanced spinal cord nerve repair10.1002/adma.202505402 ↗
42. Cartilage regeneration characteristics of human and goat auricular chondrocytes10.3389/fbioe.2021.766363 ↗